Julie Yoo is a General Partner at a16z Bio + Health. She discusses how poor data visibility causes systemic supply-demand mismatches in doctor scheduling.
Prediction Not checkable as stated
Yoo: AI task unbundling could nearly double clinical workforce capacity
“So, you know, imagine like almost doubling the capacity of a given clinical labor pool simply by applying some of these unbundling tactics.”
Insight
Yoo: Healthcare's lack of SaaS legacy enables faster AI adoption
“One of the dynamics that we believe is driving this rapid adoption cycle of these new AI tools is what we call this kind of leapfrog dynamic, where, you know, healthcare historically has been a laggard with respect to software-based technology. And we've alway…”
Prediction Not checkable as stated
Yoo: Healthcare AI will increasingly be sold as digital labor
“We're at a breaking point where the industry needs these solutions, and therefore we're going to see a much higher adoption than we've ever seen before. I think it will come in the form of these super staff. I think we will increasingly see adoption of these A…”
Assertion Partly supported
Yoo: AI insurance lawsuits stem from denial speed, not denial rates
“The rate of denials is not going up, it's the speed with which the denials are happening that's going up.”
Prediction Not checkable as stated
Yoo: Pandemic accelerates 10-year healthcare modernization trends into 2-3 years
“Now, all of those things were tailwinds that we thought would take 10 years or even longer to play out. But with the current dynamics at play during this pandemic it's more likely that those things will play out in two or three years.”
Prediction Not checkable as stated
Yoo: Consumers will sever longstanding provider relationships for affordability and access
“Affordability will become even more prominent of a focus. And as a result, I believe that consumers will be willing to sever longstanding provider relationships in the name of affordability and access.”